HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven H Swerdlow Selected Research

MEF2 Transcription Factors

12/2020The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
1/2018Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
10/2017J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven H Swerdlow Research Topics

Disease

20Lymphoma (Lymphomas)
01/2022 - 07/2002
11Neoplasms (Cancer)
01/2022 - 10/2003
9Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 03/2003
8B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2004
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2022 - 07/2004
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2016 - 10/2008
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2008 - 03/2003
3Immunoglobulin G4-Related Disease
08/2015 - 10/2014
3Lymphadenopathy
07/2014 - 10/2003
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2019 - 08/2011
2Hodgkin Disease (Hodgkin's Disease)
10/2017 - 04/2007
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2017 - 12/2014
2Disease Progression
03/2016 - 07/2004
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2015 - 08/2014
2T-Cell Lymphoma (Lymphoma, T Cell)
12/2015 - 06/2013
2Heavy Chain Disease
04/2012 - 08/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Leukemia
01/2022
1Primary Effusion Lymphoma
11/2018
1Carcinogenesis
11/2018
1Histiocytosis
03/2016
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
12/2015
1Mycosis Fungoides
12/2015
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2015
1Balanitis
10/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2014
1Enteropathy-Associated T-Cell Lymphoma
06/2013
1Thyroid Neoplasms (Thyroid Cancer)
09/2012
1Composite Lymphoma
04/2012
1Hydatidiform Mole (Molar Pregnancy)
05/2010
1Infections
09/2009
1Merkel Cell Carcinoma
09/2009
1Carcinoma (Carcinomatosis)
09/2009
1Skin Neoplasms (Skin Cancer)
09/2009
1Paraproteinemias (Monoclonal Gammopathy)
11/2008
1Chromosome Aberrations (Chromosome Abnormalities)
10/2008
1Rheumatoid Arthritis
07/2007
1Castleman Disease (Castleman's Disease)
07/2007
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
07/2007
1Kaposi Sarcoma (Kaposi's Sarcoma)
07/2007
1Sclerosis
04/2007
1Thrombocytopenia (Thrombopenia)
10/2003

Drug/Important Bio-Agent (IBA)

6Immunoglobulins (Immunoglobulin)IBA
10/2019 - 10/2003
6Biological ProductsIBA
04/2012 - 03/2003
5Cyclin D1IBA
01/2019 - 03/2003
5AntigensIBA
01/2018 - 03/2006
5Proteins (Proteins, Gene)FDA Link
10/2016 - 12/2004
4CyclinsIBA
01/2019 - 10/2003
4ParaffinIBA
05/2010 - 04/2004
3Immunoglobulin M (IgM)IBA
01/2022 - 11/2008
3MEF2 Transcription FactorsIBA
12/2020 - 10/2017
3Immunoglobulin G (IgG)IBA
08/2015 - 07/2014
2Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2008
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2020 - 01/2019
2CytokinesIBA
08/2015 - 07/2007
2RNA (Ribonucleic Acid)IBA
07/2014 - 06/2011
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2011 - 07/2002
2DNA (Deoxyribonucleic Acid)IBA
09/2009 - 12/2008
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2022
1Circular RNAIBA
11/2018
1venetoclaxIBA
10/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
03/2016
1S100 Proteins (S 100 Protein)IBA
12/2015
1InterleukinsIBA
08/2015
1Interleukin-13IBA
08/2015
1Messenger RNA (mRNA)IBA
08/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2015
1SteroidsIBA
10/2014
1Anaplastic Lymphoma KinaseIBA
08/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2013
1MitogensIBA
09/2012
1Protein Kinases (Protein Kinase)IBA
09/2012
1CryoglobulinsIBA
08/2011
1Immunoglobulin A (IgA)IBA
06/2011
1Immunoglobulin D (IgD)IBA
04/2010
1Monoclonal AntibodiesIBA
09/2009
1Oncogene Proteins (Oncogene Protein)IBA
09/2009
1Tumor Viral Antigens (Large T Antigen)IBA
09/2009
1AutoantigensIBA
06/2009
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
12/2008
1Death-Associated Protein KinasesIBA
12/2008
1Cyclin-Dependent Kinase Inhibitor p16IBA
12/2008
1Rituximab (Mabthera)FDA Link
11/2008
1Methotrexate (Mexate)FDA LinkGeneric
07/2007
1Interleukin-6 (Interleukin 6)IBA
07/2007
1Immunoglobulin Variable RegionIBA
03/2006
1Antineoplastic Agents (Antineoplastics)IBA
10/2003

Therapy/Procedure

4Therapeutics
12/2014 - 10/2003
1Splenectomy
04/2015
1Radioimmunotherapy
11/2008
1Orchiectomy (Orchidectomy)
04/2007